Lv2
108 积分 2025-07-17 加入
Neutral BackboneModifications Enhance the Pharmacokineticsand Biodistribution of Antibody–Oligonucleotide Conjugateswith High Drug-to-Antibody Ratios
3个月前
已完结
Development of a Scalable Plug-and-Play Platform for Dual-Targeting LPA and PCSK9, and Beyond, in Cardiovascular Disease Treatment
3个月前
已完结
RNAi-mediated pathways in the nucleus
4个月前
已完结
Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic
4个月前
已完结
RNAi-based drug design: considerations and future directions
4个月前
已完结
RNA-DNA hybrid binding domain broadens the editing window of base editors
4个月前
已完结
Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma
4个月前
已完结
Concurrent binding to DNA and RNA facilitates the pluripotency reprogramming activity of Sox2
4个月前
已完结
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study
5个月前
已完结
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
5个月前
已完结